Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
This global study is a multi-center, single arm study in insulin-requiring adult and pediatric subjects with type 1 diabetes on the MiniMed 780G system using Fiasp insulin as well as Medtronic Extended infusion set and reservoir. The run-in period and study period will be approximately 120 days long.
A total of up to 250 subjects with insulin-requiring type 1 diabetes age 7-80 will be enrolled at up to 25 investigational centers across the United States, Canada, and Australia in order to have 200 subjects enter the study period. Up to 125 subjects will be enrolled in the pediatric age group (7-17 years of age), up to 125 in the adult age group (18 years or older).
Location: SIMR (Sacramento/Valley Area)
Please contact: SIMR@sutterhealth.org about CIP36
Principal Investigator
Related Studies
A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians.
Managing Cardiometabolic Disease in Primary Care
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Research Aimed at Improving Both Mood and Weight (RAINBOW)
Strength Training Regimen for Normal Weight Diabetics (STRONG-D) Study
New Weigh of Life Program Evaluation
eCMP (electronic Cardiometabolic Program)
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Evaluation of Chronic Care Transformation at PAMF
Investigator: Cheryl Stults, Ph.D.